MRP3, an organic anion transporter able to transport anti-cancer drugs - Wikidata - awgldk - TriplyDB

MRP3, an organic anion transporter able to transport anti-cancer drugs

MRP3, an organic anion transporter able to transport anti-cancer drugs

http://www.wikidata.org/entity/Q24650550

about

Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues High cellular accumulation of sulphoraphane, a dietary anticarcinogen, is followed by rapid transporter-mediated export as a glutathione conjugate Transport of bile acids in multidrug-resistance-protein 3-overexpressing cells co-transfected with the ileal Na+-dependent bile-acid transporter New invMED1 element cis-activates human multidrug-related MDR1 and MVP genes, involving the LRP130 protein Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases Gene expression patterns in ovarian carcinomas Impaired clearance of methotrexate in organic anion transporter 3 (Slc22a8) knockout mice: a gender specific impact of reduced folates Multidrug resistance related molecules in human and murine lung Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs ATP-binding cassette (ABC) transporters in normal and pathological lung The role of drug transporters in the kidney: lessons from tenofovir Multidrug Resistance Proteins (MRPs) and Cancer Therapy Physiology of cholangiocytes Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions Tissue distribution and induction of human multidrug resistant protein 3 Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway Bile-salt hydrophobicity is a key factor regulating rat liver plasma-membrane communication: relation to bilayer structure, fluidity and transporter expression and function Characterization of the 5'-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) gene Regulation of multidrug resistance proteins by genistein in a hepatocarcinoma cell line: impact on sorafenib cytotoxicity Transport of fluorescein methotrexate by multidrug resistance-associated protein 3 in IEC-6 cells Single amino acid substitution of rat MRP2 results in acquired transport activity for taurocholate Molecular identification and characterization of rat Abcc1 cDNA: existence of two splicing variants and species difference in drug-resistance profile Expression of the reduced folate carrier SLC19A1 in IEC-6 cells results in two distinct transport activities Targeting multidrug resistance in cancer MRP3: a molecular target for human glioblastoma multiforme immunotherapy.Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma.Expression and localization of the multidrug resistance-associated protein 3 in rat small and large intestine.Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression. A role for BCRP in cellular folate homeostasis.ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra?Polymorphism in multidrug resistance-associated protein gene 3 is associated with outcomes in childhood acute lymphoblastic leukemia.Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma.Xenobiotic, bile acid, and cholesterol transporters: function and regulation.Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception.Bile formation and secretion.Recombinant single-chain variable fragment antibodies against extracellular epitopes of human multidrug resistance protein MRP3 for targeting malignant gliomas.Effluxing ABC transporters in human corneal epithelium.A family of drug transporters: the multidrug resistance-associated proteins.Classification of ex vivo methotrexate resistance in acute lymphoblastic and myeloid leukaemia.Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells.Mechanisms and clinical implications of renal drug excretion.

P2860

Q24533593-9A5F218C-3FB6-433E-B39C-A28B96354D15 Q24534121-D92222DD-06A8-4D44-A69A-88D7025AABA3 Q24534978-AA7D5A92-FB4D-43B9-87FA-DB76EEA59E29 Q24562993-E81CD1B5-6BCA-4DF4-9F1C-638CB8B7417F Q24601963-1E181812-C7F2-416C-A926-6917081F4BE3 Q24644996-713D7503-B83A-43FC-B95F-155F1CBACE4E Q24649482-1DA0AB29-94A4-4D37-B520-B8F8A7ED3E01 Q24673081-73EF655B-4387-4452-A51D-C000AE21C011 Q24681283-E80074FA-AED1-42DE-BD54-62B12569E8B5 Q24811895-E40A9489-4EDE-4DB1-89D6-39FDA45FBD9D Q26866489-F135C4F9-0F65-4913-B81B-F5B87D6EADEE Q26992204-FB116954-D04E-4013-BBD4-D31075F6FE74 Q27008523-9EA37610-44DB-40DC-B989-4A65EEC6E81A Q28155855-39DE8063-2317-4586-9EA7-97B82AEDFE34 Q28201985-6488A30E-3712-4628-829D-78A39C697A39 Q28238852-B7D5A4B5-853B-4D83-8A4D-D62E3195672E Q28362398-C7FFF8F7-8898-4D24-B579-3A641AFF18C2 Q28371752-2DD594C2-2E2F-4D01-9D61-D1F76F47D22D Q28544454-D4A34ADB-C294-4B72-8627-EEC8C62E7CBF Q28569608-21395AD8-CADB-4D30-A22A-577BBCBE7F38 Q28575098-9E8F1960-7C3F-49CD-AFCF-000ED9C06E8B Q28580674-AF0BFCCE-6531-4CDD-978E-945AFDAAD2F1 Q28584080-8E642F90-6EC7-4AD3-A3AD-2F11DC7691F8 Q29616803-30409C0C-0921-49FB-A487-A0B87C314E3E Q30988770-6F3B9E26-585D-46BE-8D42-1397D534F9CD Q32063211-19D8110F-646C-44FC-99B8-551D247B84D3 Q33183493-A2123851-39A6-4B5A-89E7-93B629C96AAE Q33200355-CBD447C8-1062-4738-B101-67D3C765F957 Q33281867-EE3E86FE-6FAA-4E2B-ADCD-0CFE138E4812 Q33395469-7917A751-39C0-4584-84B6-167944B65D96 Q33490314-2F43A228-102C-41D4-82AF-515DDAF18BA1 Q33714593-E9316D91-00DE-4CDB-88F3-EE8CBE865036 Q33780850-4FFB499B-4C68-4A86-ACA8-27EE78E1D122 Q33881922-3284D6E1-525B-4D65-ADB1-8E4F01B8ABD7 Q33886564-B90B28E4-DCE2-4792-A4B8-B137D6718F0A Q34003651-A1A22562-4C55-4D23-A7AF-683716DB73BD Q34004952-F87D66A9-AD27-467B-A95C-8F23D6E6CD45 Q34071693-C2D79243-7D8B-4C87-A156-2BCEC9DEA53E Q34087168-7BED7828-4FA5-4888-A05D-095A6FD258F5 Q34479011-97FD9C03-ABDB-4C03-B132-0099572B6C90

P2860

MRP3, an organic anion transporter able to transport anti-cancer drugs

http://www.wikidata.org/entity/Q24650550

description

1999 nî lūn-bûn

@nan

1999 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

MRP3, an organic anion transporter able to transport anti-cancer drugs

@ast

MRP3, an organic anion transporter able to transport anti-cancer drugs

@en

MRP3, an organic anion transporter able to transport anti-cancer drugs

@nl

type

label

MRP3, an organic anion transporter able to transport anti-cancer drugs

@ast

MRP3, an organic anion transporter able to transport anti-cancer drugs

@en

MRP3, an organic anion transporter able to transport anti-cancer drugs

@nl

prefLabel

MRP3, an organic anion transporter able to transport anti-cancer drugs

@ast

MRP3, an organic anion transporter able to transport anti-cancer drugs

@en

MRP3, an organic anion transporter able to transport anti-cancer drugs

@nl

P1433

Q24650550-688439A9-B4DE-4B80-B933-CFD0B5625093

P1476

Q24650550-473DEE3C-B5C7-480C-91C2-5C4465BA3DB4

P2093

Q24650550-050A697A-3217-4A59-87AD-0754537F0211

Q24650550-27695E9F-C90A-417A-8B8C-61C67BEC4912

Q24650550-59D86C7B-7E99-4D45-B9E8-0D9254C4CECD

Q24650550-628A7DB1-20D5-4CE4-8198-529BC13188B7

Q24650550-6F2C0769-1DCF-49B1-9851-B9604FDB2A7C

Q24650550-8EE23E44-EF7C-44CC-A156-F096EE3B30EF

Q24650550-AD9E396C-D959-4EE7-9EC9-1F1DEFD9DD30

Q24650550-B83060FA-C8BE-4CA5-B6DE-226611143A1A

Q24650550-DEF506D4-3EF5-4607-837E-41BE8638FC51

Q24650550-E5BA079C-DCC1-4E3B-A9F3-8C2240D8FAF6

P2860

Q24650550-0808E7B0-7D4F-4626-B79E-4C7D4B8B2A26

Q24650550-129F4371-40FD-45EF-9191-2F591FE563A6

Q24650550-17DC94F1-A31E-4CC1-9D3F-78BF24A48C1E

Q24650550-1A768011-6E6A-4D7C-819E-B2E6ADAB310B

Q24650550-1EB97EAC-822E-4470-AB15-AD84AE193B32

Q24650550-21773386-AC0D-4AFE-ADCE-644C4FE4CDD9

Q24650550-29E8887C-0426-46D5-8370-16DCDCA60604

Q24650550-2EBD1B09-A844-4C58-A6A5-4A66F23EBC04

Q24650550-2F0E68FD-1090-4883-BAB8-E70CC9D00B2D

Q24650550-2FF5EF59-B7C9-4ABE-84E4-E775EB1AEBC2

P304

Q24650550-C0C3CE87-56C2-4685-9F65-6D13ECDD2E08

P31

Q24650550-AD5736A0-9689-4D68-B00E-34C32E5B4D26

P356

Q24650550-647E0006-094A-4776-BF3B-AEA73EBD8547

P407

Q24650550-F6C6A985-AD89-475C-AC4E-E91CA75A1631

P433

Q24650550-368E5D92-914F-4099-9737-F75873552C5C

P478

Q24650550-EB6D67DB-FC73-4184-8D7D-CF475854492D

P50

Q24650550-9288757E-2E42-43E0-99B8-DC0D1961D014

Q24650550-B0E29ACF-FD07-491D-860B-80DD70FC8379

P577

Q24650550-A8366F15-3D25-419F-86F8-3A4229FB498C

P5875

Q24650550-2FBD2708-2579-4B29-A669-BAF40925D894

P698

Q24650550-DB2B830D-F2C6-4E90-BCB4-083B789699CB

P932

Q24650550-935DD853-B1B5-494A-B241-F65C2970DD07

P356

PNAS.96.12.6914

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

MRP3, an organic anion transporter able to transport anti-cancer drugs

@en

P2093

A J Smith

http://www.w3.org/2001/XMLSchema#string

G J Peters

http://www.w3.org/2001/XMLSchema#string

G Jansen

http://www.w3.org/2001/XMLSchema#string

G L Scheffer

http://www.w3.org/2001/XMLSchema#string

J M de Vree

http://www.w3.org/2001/XMLSchema#string

M Kool

http://www.w3.org/2001/XMLSchema#string

M van der Linden

http://www.w3.org/2001/XMLSchema#string

N Ponne

http://www.w3.org/2001/XMLSchema#string

P Borst

http://www.w3.org/2001/XMLSchema#string

R J Scheper

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2/MRP3, and its expression in cisplatin-resistant cancer cells with decreased ATP-dependent drug transport

Characterization of MOAT-C and MOAT-D, new members of the MRP/cMOAT subfamily of transporter proteins

An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs

cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3)

Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA

Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis

A comprehensive set of sequence analysis programs for the VAX

A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome

Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines

Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter

P304

6914-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.96.12.6914

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P50

P577

1999-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12938776

http://www.w3.org/2001/XMLSchema#string

P698

10359813

http://www.w3.org/2001/XMLSchema#string

P932

22016

http://www.w3.org/2001/XMLSchema#string